투자판단관련주요경영사항(임상시험계획변경승인신청) (전립선암 치료제 CPPCA07의 1상 임상시험계획 변경승인 신청)[코]
Received: 9/4/2026 · Reporter: 현대바이오
현대바이오는 전립선암 치료제 CPPCA07의 1상 임상시험계획 변경승인 신청을 했습니다.
🏢 Past 12 months filing pattern (this company)
- Total filings
- 33 filings
- Same category
- 10 filings
- Previous same-category filing
- 6/23/2026(73 days ago)
- Corrections / withdrawals
- 1 filing
Filing source / License
The original PDF/HTML of this filing is provided by FSS DART. MarketBubbles displays only metadata (title, receipt number, type, reporter) and a rule-based summary; we do not mirror the original PDF body (per FSS ToS).